Skip to main content
Journal of Patient-Reported Outcomes
Fig. 3 | Journal of Patient-Reported Outcomes

Fig. 3

From: Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray

Fig. 3

Meaningful change thresholds of QLDS using anchor- and distribution-based approach. Values represent MCT for various categories or points of improvement in QLDS score from Baseline to Day 25. For all MADRS severity criteria—one-category improvement and for EQ-VAS—7-point improvement. EQ-VAS EuroQol Visual Analog Scale, MADRS Montgomery–Åsberg Depression Rating Scale, MCT meaningful change threshold; QLDS Quality of Life in Depression Scale, SD Standard Deviation

Back to article page